Celestial Biolabs (Delisted) share news and announcements
BSE: 532871Pharmaceuticals & Biotechnology
Formerly Celestial Labs
Last traded ₹1.75 on 11 Mar 2020
Delisted on 16 Oct 2024.
Celestial Biolabs share news and announcements
634 announcements, routine notices left out, newest first. Page 12 of 13.
Jan 2011
31 Jan · Board meeting
To consider and take on record the un-audited financial results of the Company for the quarter ended December 31, 2010 and to convert the warrants into equity shares.31 Jan · Board Meeting on Feb 14, 2011
Meeting of the Board of Directors and Audit Committee of the Company will be held on February 14, 2011, inter alia, : 1. To consider ....
Nov 2010
24 Nov · Limited Review Report
Auditors have conducted the limited review for the un-audited financial results for the quarter ended September 30,2010. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.2 Nov · Board meeting
To consider and take on record the un-audited financial results of the Company for the quarter ended September 30, 2010.
Oct 2010
11 Oct · Business
Board of Directors in their Board meeting concluded on October 6, 2010 have alloted 6,20,000 equity shares of Rs. 10/- each as Sweat Equity Shares to Dr A N Singh, Chairman and Managing Director of the Company in lieu of compensation (part) for transfer of Intellectual property rights in accordance with SEBI Guidelines.
Sep 2010
30 Sep · Meeting
At the Annual General Meeting of the Company held on September 30, 2010, the following resolution have been passed: 1. Considered & adopted the Audited Accounts of the Company for the financial year ended March 30,2010 and the report of the Board of Directors and Auditor's thereon 2. Re-appointment of Dr. B Siva Kumar as a Director of the Company 3. Re-appointment of Dr. Jeetainder Roy Gaur as a Director of the Company 4. Re-appointment of G.V.Rao & Co., Chartered Accountants, as Auditors of the Company to hold office until the conclusion of next Annual General Meeting & Board of Directors is authorized to fix their remuneration. 5. Re-appointment of Dr.A.N. Sing as the Chairman and Managing Director of the Company.30 Sep · Meeting
Members at the 12th Annual General Meeting (AGM) of the Company held on September 30, 2010, inter alia, have passed the following resolutions: ....9 Sep · Meeting
Register of Members & Share Transfer Books of the Company will remain closed from September 27, 2010 to September 30, 2010 (both days inclusive) ....6 Sep · Meeting
Register of Members and Share Transfer Books of the Company will remain closed from September 27, 2010 to September 30, 2010 (both days inclusive) for the purpose of Annual General Meeting for the financial year 2009-2010 scheduled to be held on September 30, 2010.
Aug 2010
27 Aug · Limited Review for the quarter ended Jun 30, 2010
25 Aug · Limited Review Report
Auditors have conducted the limited review for the un-audited financial results for the period ended June 30,2010. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.2 Aug · Board meeting
To consider the following: 1) To consider and take on record the un-audited financial results of the Company for the quarter ended June 30, 2010 and 2) To consider the audited financial results for the Financial year ended March 31, 2010.
Jul 2010
7 Jul · Updates
Our Company has started production and marketing of 12 neutraceuticals in the domestic as well as overseas markets. We are glad to confirm that the products were developed through our in-house R & D7 Jul · Updates
Company has started production and marketing of 12 neutraceuticals in the domestic as well as overseas markets. Further the Company ....
May 2010
3 May · Board Meeting on May 10, 2010
Meeting of the Board of Directors and Audit Committee of the Company will be held on May 10, 2010, to consider the following: 1. To ....3 May · Board meeting
To consider the following: (1) To consider and take on record the Un-audited financial results of the Company for the quarter ended March 31, 2010 and (2) To allot 6,20,000 sweat equity shares to Dr. A.N. Singh, Chairman and Managing Director of the Company provided the approvals from the stock Exchanges are received prior to the date of the said Board meeting.
Apr 2010
29 Apr · Updates
Company have filed Twelve Patents for Herbal Medicines developed through in-house research facility recognized by Department of Science and ....27 Apr · Updates
We have filed Twelve Patents for Herbal Medicines developed through in-house research facility recognized by Department of Science and Industrial Research, New Delhi
Mar 2010
11 Mar · Name Change
Members of the Exchange are hereby informed that the name of Celestial Labs Limited shall be changed to Celestial Biolabs Limited w.e.f. March 17, 2010.
Feb 2010
26 Feb · Board meeting
Vide its letter dated February 26, 2010 that "The Board of Directors in their just concluded Board meeting held today have allotted 5,89,000 equity shares of Rs.10/- each as Sweat Equity Shares to Dr A N Singh, Chairman and Managing Director of the Company in lieu of compensation(part) for transfer of Intellectual property rights in accordance with SEBI Guidelines".26 Feb · Board meeting
Board of Directors of the Company at its meeting held on February 26, 2010, has allotted 5,89,000 equity shares of Rs. 10/- each as Sweat Equity ....18 Feb · Board meeting
To consider the allotment of 5,89,000 sweat equity shares to Dr. A N Singh, Chairman and Managing Director of the Company in lieu of compensation (part) for transfer of Intellectual property rights.18 Feb · Celestial Labs - Board Meeting on Feb 26, 2010
Meeting of the Board of Directors of the Company will be held on February 26, 2010, to consider the allotment of 5,89,000 sweat equity shares ....
Jan 2010
27 Jan · Board meeting
Board of Directors of the Company at its meeting held on January 25, 2010, have transacted the following business: (1) Allotment of 22,00,000 warrants convertible into equity shares within a period of 18 months at a price of Rs.27/- per warrant in accordance with SEBI Guidelines.25 Jan · Board meeting
Board of Directors of the Company at its meeting held on January 25, 2010, inter alia, have make allotment of 22,00,000 warrants convertible ....13 Jan · Board meeting
To consider the following: (1) To consider and take on record the Un-audited financial results of the Company for the quarter ended December 31, 2009 and (2) To allot 22,00,000 warrants to non promoters group. (3) To allot 5,89,000 sweat equity shares to Dr.A.N. Singh, Chairman and Managing Director of the Company provided the approvals from the stock Exchanges are received prior to the date of the said Board meeting.13 Jan · Celestial Labs - Board Meeting on Jan 25, 2010
Meeting of the Board of Directors and Audit Committee of the Company will be held on January 25, 2010, to consider the following: 1. To ....
Dec 2009
30 Dec · Change of name of the Company
Name of the Company has been changed from Celestial Labs Limited to Celestial Biolabs Limited w.e.f. December 23, 2009.22 Dec · Results
Outcome of postal ballot. Further, the Company has informed that all the resolutions were passed with requisite majority as per the report dated December 21, 2009, given by Mr.G.Mohan, Company Secretary, being the Scrutinizer appointed for the purpose. The Result of the Postal Ballot was declared on December 21, 2009, by Dr.A.N.Singh, Chairman & Managing Director of the Company. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.14 Dec · Meeting
Members at the Extra Ordinary General Meeting of the Company held on December 14, 2009, inter alia, have passed the following resolutions: 1. Changing the name of the Company from Celestial Labs Ltd. to Celestial Biolabs Ltd. 2. Increasing the Authorised Share Capital from Rs. 14.00 Crores to Rs. 17.00 Crores. 3. Increasing the Borrowing powers of the Board to Rs. 75.00 crores. 4. Issue of Sweat Equity shares in two tranches comprising of 5,89,000 and 6,20,000 equity shares to Dr. A. N. Singh.
Nov 2009
27 Nov · Utilisation of Funds
Status of utilization of fund as on September 30, 2009. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.24 Nov · Meeting
Notice of Postal Ballot along with the Notice of the Extraordinary General Meeting of the members of the Company to be held on December 14, 2009. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements) For more details click here.12 Nov · Updates
Outcome of the board meeting held on November 06, 2009 - Revised as follows: "In the intimation made to you on 06.11.2009 the number of warrants to be read as 22,00,000 instead of 8,45,000".6 Nov · Board meeting
Outcome of the meeting of the Board of Directors held on November 06, 2009. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Oct 2009
30 Oct · Board meeting
Board of Directors in their Board Meeting held on October 30, 2009 have transacted the following business : 1) To meet the financial requirements with regard to the expansion plans of the company, the Board has decided to make preferential issue upto 30,00,000 equity shares to Non Promoter/ Others subject to the approval of shareholders and other regulatory bodies. 2) To convene an Extraordinary General Meeting of the members for obtaining their consent for a) Changing the name of the Company from "Celestial Labs Limited" to "Celestial Biolabs Labs Limited" and b) Preferential issue upto 30,00,000 equity shares to non promoter/others.23 Oct · Board meeting
To consider the following: 1) To consider and take on record the un-audited financial results of the Company for the quarter ended September 30, 2009 and 2) To consider the proposal of preferential issue of equity shares to non promoter group.16 Oct · Meeting
Minutes of the Annual General Meeting of the Company held on September 30, 2009. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Sep 2009
30 Sep · Meeting
Outcome of Annual General Meeting held on September 30, 2009. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.